BeautyHealth Q3 net sales $88.8M (+30% YoY), raises FY net sales guidance; cuts EBITDA outlook

SkinHealth Systems Inc.

2022-Q3 EPS reported -$0.20 revenue$267,743,000

Net sales $88.8M (+30% YoY), seventh consecutive beat; raised FY2022 net sales guidance to $360-365M.
GAAP net income $0.1M vs loss $215.1M a year ago; adjusted net income $8.0M.
Adjusted EBITDA $16.5M (18.6% margin); FY2022 adjusted EBITDA guidance revised to $45-50M due to FX and China zero-COVID.
Americas net sales $58.4M (+30% YoY); APAC $15.1M (+44%); EMEA $15.3M (+21%).
Year-to-date delivery systems sold (6,447) already exceed full-year 2021 record of 6,191; total install base 24,473.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

SkinHealth Systems Inc. updated its third quarter ended September 30, 2022 guidance (raised).

Period: third quarter ended September 30, 2022
Guidance: raised
Result: reported results

Exact text from the filing

BeautyHealth Reports Third Quarter 2022 Financial Results Net sales beat expectations for seventh consecutive quarter Company raises 2022 net sales guidance on continued momentum and strong demand, revises adjusted EBITDA guidance against a complex macro backdrop Long Beach, Calif., November 8, 2022 – The Beauty Health Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced financial results for the third quarter ended September 30, 2022.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

SkinHealth Systems Inc. reported full year 2022 results: revenue $360 million to $365 million. Guidance raised.

Period: full year 2022
Revenue: $360 million to $365 million
Guidance: raised
Result: guidance update

Exact text from the filing

On continued momentum and strong provider and consumer demand, the Company raised its 2022 net sales guidance to $360 million to $365 million.

View on SEC.gov

168 earnings releases filed in the last 30 days. Browse all earnings releases →

SkinHealth Systems Inc. filing history →

Source: SEC EDGAR

accession 0001818093-22-000166

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.